Cell therapy solutions Learn more Gene therapy solutions Learn more Cell and gene therapy brochure Find out how Thermo Fisher Scientific can connect you to Cell and Gene Therapy products, services and solutions to help you progress. From discovery to cell and gene therapy bioprocessing and commercial...
Cell and gene therapy brochure Find out how Thermo Fisher Scientific can connect you to Cell and Gene Therapy products, services and solutions to help you progress. From discovery to cell and gene therapy bioprocessing and commercialization, Thermo Fisher Scientific is the partner to support you at...
Discover closed, scalable cell processing and electroporation systems for your GMP iPSC research and manufacturing 新! Gibco™ CTS™ Rotea™逆流离心系统-用于细胞治疗生产的封闭式细胞处理系统 多功能Gibco™ CTS™ Rotea™逆流离心系统是一种高度通用的系统,具有出色的灵活性。系统内置用户可编程的软...
Thermo Fisher Scientific announced the completion of Henogen SA, Groupe Novasep SAS’s viral vector manufacturing business in Belgium. The deal was for €725 million in cash.
"The Rotea counterflow centrifuge is the first in a family of manufacturing technologies being developed to suit the specific challenges and needs of the cell and gene therapy industry," saidBryan Poltilove, general manager of cell and gene therapy at Thermo Fisher Scientific. "The compact size,...
Thermo Fisher Scientific is set to buy viral vector manufacturer Brammer Bio for approximately $1.7 billion, in a move that signals a foray into the gene-therapy field for the life sciences equipment maker. Brammer Bio, which makes viral vectors for use in in vivo and ex vivo gene-therapy ...
Strengthened our unique customer value proposition with the opening of a new biorepository in Vacaville, California, to advance our cell and gene therapy services. We also brought additional bioproduction capacity online for single-use containers and cell cul...
The PPD clinical research business has operated a central lab operation in Highland Heights since 2002, and today it includes central lab services, biomarker operations, sample management and testing to support new therapeutics, including vaccines and cell and gene therapy products. ...
Agreement aims to enable greater access to localized advanced testing capabilities for breast and lung cancer in more than 30 countries where access to affordable advanced genomic testing is lacking or not available May 9, 2023 –Pfizer and Thermo Fisher Scientific Inc. (NYSE: TMO) ...
Cell Therapy Systems products for each step in your workflow Thermo Fisher Scientific offers products for cell therapy development and manufacturing including GMP-grade reagents, media, and consumables as well as specialized equipment, expertise and support. ...